Multifunctional drugs: A novel concept for Psychopharmacology

CNS Spectrums

Volumn 14, Issue 2, 2009, Pages 71-73

  Stahl, Stephen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; ARIPIPRAZOLE; ASENAPINE; CARIPRAZINE; CLOMIPRAMINE; CLOZAPINE; DESVENLAFAXINE; DOXEPIN; DULOXETINE; ESZOPICLONE; FLIBANSERIN; FLUOXETINE; ILOPERIDONE; LUAA24530; LURASIDONE; MILNACIPRAN; MIRTAZAPINE; OLANZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SERTRALINE; TASIMELTEON; TRAZODONE; TRIPLE REUPTAKE INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE; VORTIOXETINE; ZIPRASIDONE; ZOPICLONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; DOSE RESPONSE; DRUG CLASSIFICATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; LOW DRUG DOSE; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; TREND STUDY; DRUG THERAPY; HUMAN; MENTAL DISEASE;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY; HUMANS; MENTAL DISORDERS; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS;

EID: 63349111427     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900000213     Document Type: Article

References (5)

1. Stahl SM. Stahl's Essential Psychopharmacology 3rd ed. New York, NY: Cambridge University Press; 2008.
2. Stahl SM. Not so selective serotonin reuptake inhibitors. J Clin Psychiatry 1998;59:343-344.
3. Kim DH, Maneen MJ, Stahl SM. Building a better antipsychotic: receptor targets for the treatment of multiple symptom dimensions of schizophrenia. Neurotherapeutics 2009;6:78-85.
4. Van der Schyf CJ, Youdim MB, eds. Multifunctional drugs as neurotherapeutics. Neurotherapeutics. 2009;6(theme issue):1-201.
5. Stahl SM. Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines. CNS Spectr. 2008;13:1027-1038